HX Diagnostics lands $3.1M to diagnose infectious disease
Biotech firm HX Diagnostics, based in Emeryville, Calif., has raised $3.12 million in a first round of funding from Kleiner Perkins Caufield & Byers, Nanogen and Xiamen YST Biotech, reports peHUB. The company says its mission is to develop rapid diagnostics for seasonal and emerging infectious diseases, partcularly different strains of influenza.
Next Story: Alios nabs $8.4M to treat viruses
Previous Story: GDC 09: conference to reflect a more global game industry
About the Author, Camille Ricketts
Camille is the lead writer for GreenBeat. She came to VentureBeat from Google where she worked on its traditional platforms team, particularly in TV. Before that, she was a reporter for the Wall Street Journal in New York and London. Follow her on Twitter at @camillericketts, and follow VentureBeat on Twitter at @venturebeat.